Patents by Inventor Neeraja VAJRALA

Neeraja VAJRALA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC PHARMACEUTICAL COMPOSITIONS
    Publication number: 20240173368
    Abstract: Provided herein are pharmaceutical compositions comprising a bacterial consortium and one or more pharmaceutically acceptable excipients. Such pharmaceutical compositions can be orally administered to a subject for prevention and/or treatment of dysbiosis, dysbiosis associated conditions, inflammation, and autoimmune diseases.
    Type: Application
    Filed: September 26, 2023
    Publication date: May 30, 2024
    Inventors: Nikole KIMES, Ricardo VALLADARES, Neeraja VAJRALA
  • PHARMACEUTICAL COMPOSITIONS FOR TREATING DISEASES
    Publication number: 20240091278
    Abstract: Provided herein are pharmaceutical compositions comprising a bacterial population and one or more pharmaceutically acceptable excipients. The pharmaceutical compositions may be encompassed by containers or packaging forms. Such pharmaceutical compositions can be orally administered to a subject for prevention and/or treatment of dysbiosis, dysbiosis associated conditions, inflammation, and/or metabolic diseases. Also provided herein are methods for manufacturing the pharmaceutical composition.
    Type: Application
    Filed: September 28, 2023
    Publication date: March 21, 2024
    Inventors: Nikole KIMES, Ricardo VALLADARES, Neeraja VAJRALA
  • Therapeutic pharmaceutical compositions
    Patent number: 11806373
    Abstract: Provided herein are pharmaceutical compositions comprising a bacterial consortium and one or more pharmaceutically acceptable excipients. Such pharmaceutical compositions can be orally administered to a subject for prevention and/or treatment of dysbiosis, dysbiosis associated conditions, inflammation, and autoimmune diseases.
    Type: Grant
    Filed: May 25, 2022
    Date of Patent: November 7, 2023
    Assignee: SIOLTA THERAPEUTICS, INC.
    Inventors: Nikole Kimes, Ricardo Valladares, Neeraja Vajrala
  • THERAPEUTIC PHARMACEUTICAL COMPOSITIONS
    Publication number: 20220362313
    Abstract: Provided herein are pharmaceutical compositions comprising a bacterial consortium and one or more pharmaceutically acceptable excipients. Such pharmaceutical compositions can be orally administered to a subject for prevention and/or treatment of dysbiosis, dysbiosis associated conditions, inflammation, and autoimmune diseases.
    Type: Application
    Filed: May 25, 2022
    Publication date: November 17, 2022
    Inventors: Nikole KIMES, Ricardo VALLADARES, Neeraja VAJRALA
  • Therapeutic pharmaceutical compositions
    Patent number: 11406675
    Abstract: Provided herein are pharmaceutical compositions comprising a bacterial consortium and one or more pharmaceutically acceptable excipients. Such pharmaceutical compositions can be orally administered to a subject for prevention and/or treatment of dysbiosis, dysbiosis associated conditions, inflammation, and autoimmune diseases.
    Type: Grant
    Filed: September 14, 2021
    Date of Patent: August 9, 2022
    Assignee: Siolta Therapeutics, Inc.
    Inventors: Nikole Kimes, Ricardo Valladares, Neeraja Vajrala
  • THERAPEUTIC PHARMACEUTICAL COMPOSITIONS
    Publication number: 20210401909
    Abstract: Provided herein are pharmaceutical compositions comprising a bacterial consortium and one or more pharmaceutically acceptable excipients. Such pharmaceutical compositions can be orally administered to a subject for prevention and/or treatment of dysbiosis, dysbiosis associated conditions, inflammation, and autoimmune diseases.
    Type: Application
    Filed: September 14, 2021
    Publication date: December 30, 2021
    Inventors: Nikole KIMES, Ricardo VALLADARES, Neeraja VAJRALA